B3 Pinpointing precision medicine
Wednesday 31 August 2016
09:00-12:00
Hilton Buenos Aires : Atlantico C
Organised by the FIP Special Interest Group on Translational Research and Individualized
Medicines
Simultaneous translation in Spanish
Introduction
To provide optimal patient care, pharmacists must reduce the ongoing burden of disease by mitigating adverse drug reactions, therapeutic failures and poor adherence. In this new age of precision medicine, treatments and prevention efforts are strongly enhanced by available pharmacogenomics technology, so pharmacists must learn to use this technology to improve patient care. This session will give an update on what is new in the field of precision medicine. What should be known by practising pharmacists? What are the challenges in research, implementation and ethics?
Learning objectives
At the conclusion of this application-based session, participants will be able to:
- Evaluate the current state of the field of precision medicine, not just considering pharmacogenetics but also other “-omics” techniques
- Analyse how pharmacogenomics can improve the quality of patient care
- Investigate the challenges in implementing precision medicine, and how can we meet them
- Demonstrate the educational approaches that pharmacists and other health care professionals should consider to be able to use pharmacogenomic information effectively.
Chairs
Susanne Vijverberg (Utrecht University, Netherlands) and Christina Aquilante (University of Colorado, USA)
Programme
09:00
1) Precision medicine: More than pharmacogenetics
Colin Palmer (University of Dundee, UK)
09:40
2) Clinical value of precision medicine in paediatrics
Susanne Vijverberg (Utrecht University, Netherlands)
10:20 – 10:40 Coffee/tea break
10:40
3) Clinical value of precision medicine in oncology: The tumour perspective
Ross McKinnon (University of South Australia, Australia)
11:20
4) Educational approaches for today and tomorrow: Preparing pharmacists for precision medicine
Christina Aquilante (University of Colorado, USA)